We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser.GoogleFirefox
Sign In

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/johnson-johnson-split-jnj-stock-51636716863

Johnson & Johnson Stock Jumps on Reports It Plans to Split In Two

By
Ben Levisohn
  • Order Reprints
  • Print Article

Johnson & Johnson stock was gaining on reports it plans to split itself into two companies.

The Wall Street Journal reported that Johnson & Johnson (ticker: JNJ) plans to spin off its consumer brands, which include Aveeno, Band-Aid, Tylenol, and Listerine from its pharmaceutical division, which developed a Covid-19 vaccine, among other treatments.

Johnson...

Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.